Error message

An illegal choice has been detected. Please contact the site administrator.

Omnes Capital's investments

Sector 
Pharma
Entry Date 
2017
Business 
Venture Capital

Octimet

Development of a clinically de-risked MET kinase inhibitor for the treatment of cancers

Founded in 2016, Octimet Oncology N.V. (Belgium) is a new company (spin-off from Johnson & Johnson) that acts as a translational accelerator, focusing on creating value for investors and patients by providing rapid clinical proof of concept for cancer therapies through innovative clinical development strategies and patient centered biomarker approaches. The current focus is on its clinical stage asset OMO-1, a highly selective small molecule MET inhibitor that will be developed with specific biomarkers, whilst an additional late pre-clinical stage oncology asset 0MO-2 will also enter the portfolio.

Sector 
Business services
Entry Date 
2016
Business 
Co-Investment

Global leading software editor for the simulation of sheet metal forming in the automotive industry
Headquartered in Switzerland, the company is the reference software editor for the simulation of sheet metal forming processes to the automotive industry.
Sector 
Pharma
Entry Date 
2016
Business 
Co-Investment

French pharmaceutical company specialized in complex generics
Headquartered in France with a global footprint, the company is specialised in the manufacturing and distribution of products with challenging formulations.
Sector 
Web
Entry Date 
2016
Business 
Co-Investment

Global provider of web content management
Headquartered in Denmark , the company is a global software company with a strong footprint in the web content and customer experience management.
Sector 
Business services
Entry Date 
2014
Business 
Co-Investment

Leading environmental service provider in the Nordics
Headquartered in Finland, the company is a leading provider of business services in Sweden and Finland. With more than 650 employees and 33 facilities, the group provides three complementary services: industrial cleaning, demolition and waste treatment.
Sector 
Consumer goods
Entry Date 
2014
Business 
Co-Investment

Global leader in the market of high-end home audio
Headquartered in the United Sates, the company is one of the global leader on high-end home audio.
Sector 
Infrastructure
Entry Date 
2014
Business 
Renewable Energy

Villages Nature

13 MW geothermal heating network
The project is to build and operate a geothermal power plant that will supply a heating network providing hot water and heating to Euro Disney and a Pierre et Vacances holiday park. The plan is for the heating network to add further customers in the future (business parks, shopping centres). This is the Renewable Energy team’s first heating network. Omnes Capital acquired a 51% stake in this installation.
Sector 
Pharma
Entry Date 
2013
Business 
Venture Capital

Opsona Therapeutics

Novel therapeutic approaches to key targets of the innate immune system
Opsona is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, including autoimmune and inflammatory diseases, transplant rejection, cancer, diabetes, Alzheimer's disease and atherosclerosis. The company was founded in 2004 by three world-renowned immunologists at Trinity College in Dublin.
Sector 
Medical devices
Entry Date 
2013
Business 
Venture Capital

Gecko Biomedical

Next-generation biodegradable adhesives for surgical sutures

Founded in 2013, Gecko Biomédical specialises in the development of innovative systems designed to close internal surgical wounds and specifically aims to meet the critical clinical need for sutures in mini-invasive surgery.
The company manufactures biodegradable and biocompatible elastic polymers in liquid film form and adhesive patches that can be adhered through light-activation by the surgeon, even in the presence of blood. Gecko Biomedical aims to employ its revolutionary products to complement or replace suture points when closing surgical wounds, currently one of the major challenges in medicine.

 

Sector 
Construction and building materials
Entry Date 
2013
Business 
Small-Cap Buyout & Growth Capital
Sales 
€80 million in 2014

HTI

Construction services

Organised into two business divisions (construction of telescopic access platforms and construction equipment, construction equipment rental), the HTI group offers a full range of services in its areas of expertise.

Pages

NewsRoom
No result found.